MedTrace Logo

Clinical Trial Scheme of Shu Gan yi Yang Capsule

NCT03290313 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2017-09-25

No results posted yet for this study

Summary

Shu gan yi yang capsule is made of traditional Chinese medicine Guizhou Yi Bai pharmaceutical Limited by Share Ltd, for liver and kidney deficiency and liver and kidney deficiency and blood stasis caused by functional impotence and mild arterial insufficiency in impotence, impotence, flaccid penis not hard or lift and not firm, chest deep sigh, chest fullness, soreness and weakness of waist and knees, pale tongue or petechiae, pulse string or string. The choice of depression associated with erectile dysfunction patients, and investigate its effect.In this study, patients with depression and erectile dysfunction were selected and the efficacy was investigated

Conditions

  • Depression With Erectile Dysfunction

Interventions

DRUG

shu gan yi yang capsule

Patients who did not use any antidepressants were given normal clinical medication； Patients who have been treated with antidepressants have been treated for more than 1 month and have reached a therapeutic dose without having to adjust the drug and dose within 2 months.In the original treatment on the basis of the same type of load to the clinical trial medication

DRUG

shu gan yi yang capsule simulation agent

Patients who did not use any antidepressants were given normal clinical medication； Patients who have been treated with antidepressants have been treated for more than 1 month and have reached a therapeutic dose without having to adjust the drug and dose within 2 months.In the original treatment on the basis of the same type of load to the clinical trial medication

OTHER

Supportive psychotherapy

Each patient was given cognitive behavioral adjustment and supportive psychotherapy during the clinical trial

Sponsors & Collaborators

  • Guizhou Yi Bai Pharmaceutical Co., Ltd.

    collaborator UNKNOWN

  • Peking University Sixth Hospital

    collaborator OTHER

  • Beijing HuiLongGuan Hospital

    collaborator OTHER

  • Beijing Hospital of Traditional Chinese Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-30
Primary Completion
2018-09-30
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290313 on ClinicalTrials.gov